Profile of PD-1 and PD-L1 mRNA Expression in Peripheral Blood of Nasopharyngeal Carcinoma

Abstract

Background: Programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) expression is associated with prognostic and respond to immunotherapy with immune checkpoint inhibitor in several solid malignancies. However, the prognostic roles of PD-1 and PD-L1 expression in nasopharyngeal carcinoma (NPC) are less clear. This study aims to investigate PD-1 and PD-L1 mRNA expression levels in peripheral blood of Indonesian NPC patients and its association with clinicopathological features.Materials and Methods: This study used blood samples of 21 NPC patients and 10 healthy volunteers as controls. Real-time polymerase chain reaction (PCR) was used to measure mRNA expression of PD-1 and PD-L1.Results: PD-1 mRNA expression levels were significantly lower in NPC patients (∆CT mean: 9.65±2.04) compared to healthy individuals (∆CT mean: 8.04±1.51) (p=0.031). In contrast, PD-L1 mRNA expression levels were higher in NPC patients (∆CT mean: 6.96±1.32) compared to healthy individuals (∆CT mean: 7.11±0.55), but the difference was not statistically significant (p=0.554). The expression of PD-1 was associated with tumour-node-metastasis (TNM) stage (p=0.030) but not associated with age (p=1.000), sex (p=1.000), body mass index (p=0.350), tumor stage (p=0.338), nodal stage (p=0.579), metastasis stage (p=0.371), and Eastern Cooperative Oncology Group (ECOG) status (p=0.228). Meanwhile PD-L1 expression was not associated with all clinicophatological features.Conclusion: The PD-1 mRNA expression levels were significantly lower, while PD-L1 expression levels were higher in NPC patients compared to healthy controls. PD-1 expression was correlated with TNM stage.Keywords: nasopharyngeal carcinoma, immune checkpoint inhibitors, PD-1, PD-L1

Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced Breast Cancer

“…It has 2 ligands including programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2) (Pardoll, 2012;Topalian et al, 2016). Expression of PD-L1 is highly expressed in cancer patients (Azhar et al, 2020;Wang et al, 2016) and associated with poor prognosis in several cancer types (Zhang et al, 2017). However, PD-L1 expression in breast cancer is still controversial with some studies reporting conflicting results (Schalper et al, 2014;Zhang et al, 2017).…”

Potency of Peripheral Blood- and Umbilical Cord Blood-derived Dendritic Cells and Their Secretomes as Vaccines for Cancer

“…Immunotherapy has emerged as an effective treatment for many types of cancer. 1 Dendritic cells (DC) vaccine was used as an immunotherapy agent that has the capacity to pick up and deliver antigens associated with cancer to T lymphocytes, inducing potent effector responses against cancer. The important role of DC is to mediate innate immune responses, induce adaptive immune responses, and activate memory cells.…”

Curcuma xanthorrhiza Rhizome Extract Induces Apoptosis in HONE-1 Nasopharyngeal Cancer Cells Through Bid

“…(2) NPC is generally treated with radiotherapy, while combination of radiotherapy and chemotherapy is used to treat advance-stage NPC. (3)(4)(5) Standard treatments have been reported to cause numerous adverse effects, some of which are permanent. (6) Advancement in cancer treatment and the discovery of novel anticancer agents is constantly growing.…”